OKL-1013

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOKL-1013
Drug Alias NameOKL-NS1 program (Okklo Life Sciences)cyclodextrin based therapeutics (Okklo Life Sciences)OKL-1013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOkklo Life Sciences BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOkklo Life Sciences BV
Active IndicationsN/A
Inactive IndicationsNeuritis

Other Information

ATC CodeN/A
Related LinksN/A